For years, patients with a rare bone cancer, myelofibrosis, have faced a dead end. So, when Inrebic, the first new therapy in a decade came to market, we not only wanted to make HCPs aware of this new option but also truly experience the relentless symptoms that were causing their patients to suffer. The unbearable night sweats, the non-stop fatigue, and the overwhelming burden of an enlarged spleen.

“The See What They Feel” campaign brought patients’ symptoms to life in surprising, dramatic ways, making it nearly impossible to ignore the problem any longer.